Moderna seeks EU authorization for COVID-19 vaccine in young children

FILE PHOTO: An employee shows the Moderna COVID-19 vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, U.S., December 21, 2020. REUTERS/Eduardo Munoz

(Reuters) -Moderna Inc on Tuesday applied for European authorization of its COVID-19 vaccine in children aged 6-11 years, weeks after it delayed a similar filing with U.S. regulators.

The European Union had in July authorised the vaccine for use in teens aged 12 to 17 years, but several countries including Sweden paused its use for people aged 30 and younger due to rare heart-related side-effects.